Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
559 ARTÍCULOS , VIENDO DEL 136 AL 150
Therapeutic potential of glutaminyl cyclases: Current status and emerging trends
Coimbra JRM, Moreira PI, Santos AE, Salvador JAR.
Drug Discov Today. 2023 Oct;28(10):103644. doi: 10.1016/j.drudis.2023.103644. Epub 2023 May 26.
Therapeutic Potential of Nanomedicine in Management of Alzheimer's Disease and Glioma
Anwar F, Al-Abbasi FA, Naqvi S, Sheikh RA, Alhayyani S, Asseri AH, Asar TO, Kumar V.
Int J Nanomedicine. 2023 May 22;18:2737-2756. doi: 10.2147/IJN.S405454. eCollection 2023.
Zhang J, Zheng X, Zhao Z.
BMC Neurol. 2023 May 31;23(1):210. doi: 10.1186/s12883-023-03191-w.
Is Vitamin D Supplementation a Danger to Potential Treatments of Alzheimer's Disease Treatment?
Shih PY, Yong SB, Liu CM, Cheng-Chung Wei J.
Curr Alzheimer Res. 2023;20(2):59-62. doi: 10.2174/1567205020666230530095421.
Javed B, Javed A, Kow CS, Hasan SS.
Expert Rev Neurother. 2023 Jun;23(6):501-514. doi: 10.1080/14737175.2023.2214316. Epub 2023 Jun 2.
Dysbiosis and Alzheimer's disease: role of probiotics, prebiotics and synbiotics
Thakkar A, Vora A, Kaur G, Akhtar J.
Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):2911-2923. doi: 10.1007/s00210-023-02554-x. Epub 2023 Jun 7.
CRISPR-Cas9 in Alzheimer's disease: Therapeutic trends, modalities, and challenges
Chacko L, Chaudhary A, Singh B, Dewanjee S, Kandimalla R.
Drug Discov Today. 2023 Aug;28(8):103652. doi: 10.1016/j.drudis.2023.103652. Epub 2023 Jun 7.
Burns LH, Pei Z, Wang HY.
Drug Dev Res. 2023 Sep;84(6):1085-1095. doi: 10.1002/ddr.22085. Epub 2023 Jun 8.
Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease
Su M, Nizamutdinov D, Liu H, Huang JH.
Int J Mol Sci. 2023 May 25;24(11):9272. doi: 10.3390/ijms24119272.
Advances of computer-aided drug design (CADD) in the development of anti-Azheimer's-disease drugs
Niu Y, Lin P.
Drug Discov Today. 2023 Aug;28(8):103665. doi: 10.1016/j.drudis.2023.103665. Epub 2023 Jun 9.
BACE-1 Inhibitors Targeting Alzheimer's Disease
Monteiro KLC, Dos Santos Alcântara MG, Freire NML, Brandão EM, do Nascimento VL, Dos Santos Viana LM, de Aquino TM, da Silva-Júnior EF.
Curr Alzheimer Res. 2023;20(3):131-148. doi: 10.2174/1567205020666230612155953.
Lutshumba J, Wilcock DM, Monson NL, Stowe AM.
Neurobiol Dis. 2023 Aug;184:106202. doi: 10.1016/j.nbd.2023.106202. Epub 2023 Jun 15.
Crosstalk between Alzheimer's disease and diabetes: a focus on anti-diabetic drugs
Goodarzi G, Tehrani SS, Fana SE, Moradi-Sardareh H, Panahi G, Maniati M, Meshkani R.
Metab Brain Dis. 2023 Aug;38(6):1769-1800. doi: 10.1007/s11011-023-01225-3. Epub 2023 Jun 19.
siRNA drug delivery across the blood-brain barrier in Alzheimer's disease
Imran Sajid M, Sultan Sheikh F, Anis F, Nasim N, Sumbria RK, Nauli SM, Kumar Tiwari R.
Adv Drug Deliv Rev. 2023 Aug;199:114968. doi: 10.1016/j.addr.2023.114968. Epub 2023 Jun 21.
Middleton LT, Touchon J, Vellas B.
J Prev Alzheimers Dis. 2023;10(3):331-332. doi: 10.14283/jpad.2023.69.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.